Breast cancer treatment is the same no matter hormone receptor pattern.

• A. Not always
• B. Depends on receptor pattern
• C. True
• D. False

Answer: (D)

Treatments are chosen based on the tumor’s receptor status. Breast cancers that express estrogen or progesterone receptors (ER/PR positive) respond to endocrine therapies that block estrogen signaling or reduce estrogen levels, often used for years to lower recurrence risk. Tumors that overexpress HER2 (HER2 positive) benefit from HER2-targeted therapies that specifically attack that protein. If a cancer is negative for both hormone receptors and HER2 (triple-negative), those targeted options aren’t available, so chemotherapy and, in some cases, immunotherapy are used more prominently. While surgery and radiation are common across cases, the systemic treatment plan changes with receptor pattern. So saying the treatment is the same no matter the receptor pattern is not correct.